Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.
about
Neuroprotective effect of lovastatin by inhibiting NMDA receptor1 in 6-hydroxydopamine treated PC12 cellsHyperlipidemia and statins affect neurological outcome in lumbar spine injuryLovastatin induces neuroprotection by inhibiting inflammatory cytokines in 6-hydroxydopamine treated microglia cellsStatin Use and the Risk of Parkinson's Disease: An Updated Meta-AnalysisParkinson's disease between internal medicine and neurologyAging of perennial cells and organ parts according to the programmed aging paradigm.Statins and neuroprotection: basic pharmacology needed.Liver X receptors and cholesterol metabolism: role in ventral midbrain development and neurodegeneration.Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database.Can Cholesterol Metabolism Modulation Affect Brain Function and Behavior?Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis.Statin therapy prevents the onset of Parkinson disease in patients with diabetes.Statins are ineffective at reducing neuroinflammation or prolonging survival in scrapie-infected mice.Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson's Disease: Rationale for Clinical Trial, and Current Progress.Statins and Cognition in Parkinson's Disease.Exploring the Association between Statin Use and the Risk of Parkinson's Disease: A Meta-Analysis of Observational Studies.Drug delivery to the brain: how can nanoencapsulated statins be used in the clinic?Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways.Simvastatin Inhibits Activation of NADPH Oxidase/p38 MAPK Pathway and Enhances Expression of Antioxidant Protein in Parkinson Disease Models.
P2860
Q34547840-3F737519-2F26-446B-B5C5-A24E0ECA89BBQ35015086-EFB58C2C-CA3A-4F46-A5EA-FCDBE115AE01Q35959336-D9FDA27A-3A0F-44D1-A750-0EA172A2BC11Q35971467-98DE56F1-BAE5-43D7-B620-2B010AFA047CQ36464243-AFBB75D7-DC33-4CCC-BD97-CDBD84599270Q37219569-AF7815DD-9DDF-467C-A65D-578A7283584FQ38182926-EA918C90-B779-426C-968A-594E24B45D87Q38534041-0FE7F2E5-CD35-4822-AFBD-D68AD3728279Q38859501-2998253E-E27A-4F78-B267-EA10D595197AQ38896297-BB5381B6-431E-430D-ACE8-D9495CFE328CQ38928422-0D9CF1EB-3C6F-43BB-B1C8-93F232766E8FQ39546196-97990FDC-8777-40FB-A5EA-230962A741B3Q40101603-EF42E919-3782-489B-B21E-ACE2E8E336D9Q45201060-083FD39A-43F8-4202-8882-F2A2F942429AQ46305058-1F653981-A4F2-4211-90B3-4BF5D3ABD207Q47585241-4AA7D184-C509-437A-A68E-364D3A0F0585Q48185768-CBAD1F9C-D4C1-42F7-8A53-DE0609AE8534Q48565252-F8D7D751-E151-4C08-939A-FA174CA874B8Q54976937-1B16599A-18E6-47E9-84C1-8822011D0619
P2860
Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.
@en
Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.
@nl
type
label
Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.
@en
Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.
@nl
prefLabel
Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.
@en
Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.
@nl
P2093
P2860
P1433
P1476
Statin use and risk of Parkinson's disease: a meta-analysis of observational studies
@en
P2093
Dipika Bansal
Kapil Gudala
Swathi Malla
P2860
P2888
P304
P356
10.1007/S00415-012-6606-3
P577
2012-07-21T00:00:00Z